Saroja Pharma Industries India (NSE:SAROJA) EPS (Basic): ₹2.57 (TTM As of Mar. 2025)


NSE:SAROJA Saroja Pharma Industries India Ltd NSE:SAROJA
16 GF Score
Price ₹33.00
! 4 Warning Signs
View Full Analysis

What is Saroja Pharma Industries India EPS (Basic)?

Saroja Pharma Industries India NSE:SAROJA 16 EPS (Basic) is ₹2.57 as of Mar. 2025. GuruFocus rates NSE:SAROJA with a GF Score™ of 16/100. The stock has 4 warning signs investors should review.

Saroja Pharma Industries India's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was ₹2.57. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2.57.

Saroja Pharma Industries India's EPS (Diluted) for the six months ended in Mar. 2025 was ₹2.57. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2.57.

Saroja Pharma Industries India's EPS without NRI for the six months ended in Mar. 2025 was ₹2.57. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 2.57.

During the past 12 months, Saroja Pharma Industries India's average EPS without NRIGrowth Rate was 3.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was -3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Saroja Pharma Industries India's highest 3-Year average EPS without NRI Growth Rate was 11.10% per year. The lowest was -3.30% per year. And the median was 3.90% per year.

Saroja Pharma Industries India  (NSE:SAROJA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Saroja Pharma Industries India EPS (Basic) Related Terms

Saroja Pharma Industries India EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Saroja Pharma Industries India's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saroja Pharma Industries India EPS (Basic) Chart

Saroja Pharma Industries India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
1.82 2.84 2.64 2.49 2.57

Saroja Pharma Industries India Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic) 1.82 2.84 2.64 2.49 2.57
NSE:SAROJA
16GF Score
Saroja Pharma Industries India Ltd NSE:SAROJA
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saroja Pharma Industries India EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Saroja Pharma Industries India's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10.342-0)/4.020
=2.57

Saroja Pharma Industries India's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10.342-0)/4.020
=2.57

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹2.57 mean?
Saroja Pharma Industries India (NSE:SAROJA) has a EPS (Basic) of ₹2.57 as of Mar. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Saroja Pharma Industries India and its competitors.
Is Saroja Pharma Industries India's EPS (Basic) too high?
Saroja Pharma Industries India's current EPS (Basic) is ₹2.57. Overall, Saroja Pharma Industries India has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's EPS (Basic) compare to ZTS?
Saroja Pharma Industries India's EPS (Basic) of ₹2.57 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Saroja Pharma Industries India and its competitors. Saroja Pharma Industries India's current EPS (Basic) is ₹2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current EPS (Basic) of ₹2.57. The current EPS (Basic) is ₹2.57. Saroja Pharma Industries India's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current EPS (Basic) is ₹2.57 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Saroja Pharma Industries India Business Description

Address Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
16GF Score

Get the complete analysis for NSE:SAROJA

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.00
Price